RICCARDO DI FIORE

Dr. RICCARDO DI FIORE

University of Malta, Valletta, Malta
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2015 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
WGWilliam H. Goodson
William H. Goodson
LLLeroy Lowe
Leroy Lowe
DCDavid O. Carpenter
David O. Carpenter
MGMichael Gilbertson
Michael Gilbertson
AAAbdul Manaf Ali
Abdul Manaf Ali
Zhiwei HuZhiwei Hu
Zhiwei Hu
Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide, but credible estimates from the World Health Organization and the International Agency for Research on Cancer (IARC) suggest that the fraction of cancers attributable to toxic environmental exposures is between 7% and 19%. To explore the hypothesis that low-dose exposures to mixtures of chemicals in the environment may be combining to contribute to environmental carcinogenesis, we reviewed 11 hallmark phenotypes of cancer, multiple priority target sites for disruption in each area and prototypical chemical disruptors for all targets, this included dose-response characterizations, evidence of low-dose effects and cross-hallmark effects for all targets and chemicals. In total, 85 examples of chemicals were reviewed for actions on key pathways/mechanisms related to carcinogenesis. Only 15% (13/85) were found to have evidence of a dose-response threshold, whereas 59% (50/85) exerted low-dose effects. No dose-response information was found for the remaining 26% (22/85). Our analysis suggests that the cumulative effects of individual (non-carcinogenic) chemicals acting on different pathways, and a variety of related systems, organs, tissues and cells could plausibly conspire to produce carcinogenic synergies. Additional basic research on carcinogenesis and research focused on low-dose effects of chemical mixtures needs to be rigorously pursued before the merits of this hypothesis can be further advanced. However, the structure of the World Health Organization International Programme on Chemical Safety ‘Mode of Action’ framework should be revisited as it has inherent weaknesses that are not fully aligned with our current understanding of cancer biology.

18 April 2013 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
RICCARDO DI FIORERICCARDO DI FIORE
RICCARDO DI FIORE
Antonella D'AnneoAntonella D'Anneo
Antonella D'Anneo
GTGiovanni Tesoriere
Giovanni Tesoriere
RVRenza Vento
Renza Vento

31 October 2013 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
Antonella D'AnneoAntonella D'Anneo
Antonella D'Anneo
DCDaniela Carlisi
Daniela Carlisi
MLM Lauricella
M Lauricella
RPRoberto Puleio
Roberto Puleio
RMR Martinez
R Martinez
GTG Tesoriere
G Tesoriere
Triple-negative breast cancers (TNBCs) are clinically aggressive forms associated with a poor prognosis. We evaluated the cytotoxic effect exerted on triple-negative MDA-MB231 breast cancer cells both by parthenolide and its soluble analogue dimethylamino parthenolide (DMAPT) and explored the underlying molecular mechanism. The drugs induced a dose- and time-dependent decrement in cell viability, which was not prevented by the caspase inhibitor z-VAD-fmk. In particular in the first hours of treatment (1–3 h), parthenolide and DMAPT strongly stimulated reactive oxygen species (ROS) generation. The drugs induced production of superoxide anion by activating NADPH oxidase. ROS generation caused depletion of thiol groups and glutathione, activation of c-Jun N-terminal kinase (JNK) and downregulation of nuclear factor kB (NF-kB). During this first phase, parthenolide and DMAPT also stimulated autophagic process, as suggested by the enhanced expression of beclin-1, the conversion of microtubule-associated protein light chain 3-I (LC3-I) to LC3-II and the increase in the number of cells positive to monodansylcadaverine. Finally, the drugs increased RIP-1 expression. This effect was accompanied by a decrement of pro-caspase 8, while its cleaved form was not detected and the expression of c-FLIPS markedly increased. Prolonging the treatment (5–20 h) ROS generation favoured dissipation of mitochondrial membrane potential and the appearance of necrotic events, as suggested by the increased number of cells positive to propidium iodide staining. The administration of DMAPT in nude mice bearing xenografts of MDA-MB231 cells resulted in a significant inhibition of tumour growth, an increment of animal survival and a marked reduction of the lung area invaded by metastasis. Immunohistochemistry data revealed that treatment with DMAPT reduced the levels of NF-kB, metalloproteinase-2 and -9 and vascular endothelial growth factor, while induced upregulation of phosphorylated JNK. Taken together, our data suggest a possible use of parthenolide for the treatment of TNBCs.

14 April 2016 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
DCDaniela Carlisi
Daniela Carlisi
GBG Buttitta
G Buttitta
RICCARDO DI FIORERICCARDO DI FIORE
RICCARDO DI FIORE
CSChristian Scerri
Christian Scerri
RDR Drago-Ferrante
R Drago-Ferrante
GTG Tesoriere
G Tesoriere
Triple-negative breast cancers (TNBCs) are aggressive forms of breast carcinoma associated with a high rate of recidivism. In this paper, we report the production of mammospheres from three lines of TNBC cells and demonstrate that both parthenolide (PN) and its soluble analog dimethylaminoparthenolide (DMAPT) suppressed this production and induced cytotoxic effects in breast cancer stem-like cells, derived from dissociation of mammospheres. In particular, the drugs exerted a remarkable inhibitory effect on viability of stem-like cells. Such an effect was suppressed by N-acetylcysteine, suggesting a role of reactive oxygen species (ROS) generation in the cytotoxic effect. Instead z-VAD, a general inhibitor of caspase activity, was ineffective. Analysis of ROS generation, performed using fluorescent probes, showed that both the drugs stimulated in the first hours of treatment a very high production of hydrogen peroxide. This event was, at least in part, a consequence of activation of NADPH oxidases (NOXs), as it was reduced by apocynin and diphenylene iodinium, two inhibitors of NOXs. Moreover, both the drugs caused downregulation of Nrf2 (nuclear factor erythroid 2-related factor 2), which is a critical regulator of the intracellular antioxidant response. Prolonging the treatment with PN or DMAPT we observed between 12 and 24 h that the levels of both superoxide anion and hROS increased in concomitance with the downregulation of manganese superoxide dismutase and catalase. In addition, during this phase dissipation of mitochondrial membrane potential occurred together with necrosis of stem-like cells. Finally, our results suggested that the effect on ROS generation found in the first hours of treatment was, in part, responsible for the cytotoxic events observed in the successive phase. In conclusion, PN and DMAPT markedly inhibited viability of stem-like cells derived from three lines of TNBCs by inducing ROS generation, mitochondrial dysfunction and cell necrosis.

21 January 2009 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
RICCARDO DI FIORERICCARDO DI FIORE
RICCARDO DI FIORE
ASAndrea Santulli
Andrea Santulli
RFRosa Drago Ferrante
Rosa Drago Ferrante
MGMichela Giuliano
Michela Giuliano
ABAnna De Blasio
Anna De Blasio
RVRenza Vento
Renza Vento

5 November 2014 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
DCDaniela Carlisi
Daniela Carlisi
MLMarianna Lauricella
Marianna Lauricella
Antonella D'AnneoAntonella D'Anneo
Antonella D'Anneo
GBGiuseppina Buttitta
Giuseppina Buttitta
Sonia EmanueleSonia Emanuele
Sonia Emanuele
GTGiovanni Tesoriere
Giovanni Tesoriere